These reductions in postsynaptic and presynaptic GABAB receptors likely contribute to the pathology and memory impairment described in the APP/PS1 model of AD, providing new insights to understand the pathological events taking place in the disease. The gene discussed is PSEN1; the disease is Alzheimer disease.